company background image
ISOFOL logo

Isofol Medical OM:ISOFOL Stock Report

Last Price

kr0.76

Market Cap

kr122.4m

7D

3.6%

1Y

28.0%

Updated

27 Mar, 2024

Data

Company Financials

Isofol Medical AB (publ)

OM:ISOFOL Stock Report

Market Cap: kr122.4m

ISOFOL Stock Overview

Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally.

ISOFOL fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Isofol Medical AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Isofol Medical
Historical stock prices
Current Share Pricekr0.76
52 Week Highkr1.24
52 Week Lowkr0.45
Beta1.48
1 Month Change31.14%
3 Month Change26.33%
1 Year Change28.04%
3 Year Change-96.11%
5 Year Change-96.98%
Change since IPO-97.19%

Recent News & Updates

Recent updates

An Intrinsic Calculation For Isofol Medical AB (publ) (STO:ISOFOL) Suggests It's 45% Undervalued

May 18
An Intrinsic Calculation For Isofol Medical AB (publ) (STO:ISOFOL) Suggests It's 45% Undervalued

Here's Why We're Not At All Concerned With Isofol Medical's (STO:ISOFOL) Cash Burn Situation

Nov 09
Here's Why We're Not At All Concerned With Isofol Medical's (STO:ISOFOL) Cash Burn Situation

Is Isofol Medical (STO:ISOFOL) In A Good Position To Deliver On Growth Plans?

May 12
Is Isofol Medical (STO:ISOFOL) In A Good Position To Deliver On Growth Plans?

Market Sentiment Around Loss-Making Isofol Medical AB (publ) (STO:ISOFOL)

Apr 08
Market Sentiment Around Loss-Making Isofol Medical AB (publ) (STO:ISOFOL)

Isofol Medical (STO:ISOFOL) Has Gifted Shareholders With A Fantastic 127% Total Return On Their Investment

Mar 03
Isofol Medical (STO:ISOFOL) Has Gifted Shareholders With A Fantastic 127% Total Return On Their Investment

We Think Isofol Medical (STO:ISOFOL) Needs To Drive Business Growth Carefully

Jan 10
We Think Isofol Medical (STO:ISOFOL) Needs To Drive Business Growth Carefully

Shareholder Returns

ISOFOLSE BiotechsSE Market
7D3.6%1.4%1.9%
1Y28.0%5.1%17.1%

Return vs Industry: ISOFOL exceeded the Swedish Biotechs industry which returned 6.3% over the past year.

Return vs Market: ISOFOL exceeded the Swedish Market which returned 19% over the past year.

Price Volatility

Is ISOFOL's price volatile compared to industry and market?
ISOFOL volatility
ISOFOL Average Weekly Movement17.1%
Biotechs Industry Average Movement8.9%
Market Average Movement6.1%
10% most volatile stocks in SE Market12.9%
10% least volatile stocks in SE Market3.4%

Stable Share Price: ISOFOL's share price has been volatile over the past 3 months.

Volatility Over Time: ISOFOL's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
20083Petter Lindqvisthttps://isofolmedical.com

Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm.

Isofol Medical AB (publ) Fundamentals Summary

How do Isofol Medical's earnings and revenue compare to its market cap?
ISOFOL fundamental statistics
Market capkr122.43m
Earnings (TTM)-kr37.07m
Revenue (TTM)kr721.00k

169.8x

P/S Ratio

-3.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ISOFOL income statement (TTM)
Revenuekr721.00k
Cost of Revenuekr35.14m
Gross Profit-kr34.41m
Other Expenseskr2.66m
Earnings-kr37.07m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 08, 2024

Earnings per share (EPS)-0.23
Gross Margin-4,773.23%
Net Profit Margin-5,141.61%
Debt/Equity Ratio0%

How did ISOFOL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.